产品详情
文献和实验
相关推荐
General Liquid Handling
Analytical Systems
Ion Channel Technology
Reagents
欧罗拉生物科技有限公司是生命科学、环境科学、药物研发/安全和化学分析研究等实验室自动化方案设计与研发的全球性领导*。我们提供的技术与服务可以在提高质量、准确度和精确度的同时提高样品处理量，我们致力于提高人类生活质量及环境的可持续性。2007年，Aurora Biomed开设了其亚洲销售和服务中心（佛山市顺德区欧罗拉生物科技有限公司），以促进向快速增长的亚洲市场的扩张。为了进一步扩大Aurora的市场范围，我们在全球80多个国家建立了积极的经销商网络，为客户提供销售和服务支持。
产品包括：自动化液体处理工作站、原子吸收光谱仪、原子荧光光谱仪、离子通道筛选技术和微波消解系统，它们可以在众多的应用领域中提供高销量的样品处理。我们的总部设在加拿大，并在全球有多个销售、技术支持和售后服务点。
自1990年以来，Aurora一直通过开发创新的实验室解决方案为全球科学研究界服务。Aurora集团总部位于加拿大温哥华，开始生产基于电容耦合等离子体发射专利技术的分析仪器。2000年，Aurora成为第一个开发非放射性、无标签技术，用于离子通道和转运体靶的研究和高通量筛选的公司。这项技术已迅速融入许多药物研发项目和学术实验室。利用在高通量技术方面的专业知识，Aurora将其产品扩展到包括VERSA系列的自动化液体处理平台，旨在生命科学、分子诊断和精准医疗领域。我们致力于提高人类和环境健康的质量，提供产品和服务，以促进更高的通量，同时提高质量、准确性和精确度。
自2003年起，Aurora是每年精密医疗和离子通道年会的主办方。会议旨在将业界和领先的学术研究人员聚集在一起，分享知识、交流想法，并建立富有成效的合作伙伴关系。该会议每年在加拿大和中国之间轮流召开，吸引世界各地的科学家就药物研发和个性化医学展开发人深省的讨论。它使Aurora和社会能够掌握尖端技术和创新研究的脉搏。
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a patented capacitively coupled plasma emission technology. In 2000, Aurora became the first to develop a non-radioactive, label-free technology for the study and high throughput screening of ion channel and transporter targets. This technology has been rapidly incorporated into many pharmaceutical drug discovery pipelines and academic labs. Capitalizing on this expertise in high throughput technologies, Aurora expanded its products to include the VERSA series of automated liquid handling platforms aimed at the life science, molecular diagnostics, and precision medicine fields. We are committed to improving the quality of human and environmental health by providing products and services that facilitate higher throughput while enhancing quality, accuracy, and precision.
Since 2003, Aurora been the host of the annual Precision Medicine and Ion Channel Retreat. This conference, designed to bring together industry and leading academic researchers to share knowledge, exchange ideas, and establish fruitful partnerships. This conference alternates every year between Canada and China, attracting leading scientists from around the world to engage in thought-provoking discussions on drug discovery and personalized medicine. It allows Aurora and the community to keep a pulse on cutting edge technology and innovative research.
In 2007, Aurora Biomed opened its Asia sales and services center to facilitate expansion into the rapidly growing Asia market. To further expand Aurora’s market reach, an active network of distributors based in over 80 countries worldwide, providing sales and service support to customers, was developed.
Analytical Systems
Ion Channel Technology
Reagents
欧罗拉生物科技有限公司是生命科学、环境科学、药物研发/安全和化学分析研究等实验室自动化方案设计与研发的全球性领导*。我们提供的技术与服务可以在提高质量、准确度和精确度的同时提高样品处理量，我们致力于提高人类生活质量及环境的可持续性。2007年，Aurora Biomed开设了其亚洲销售和服务中心（佛山市顺德区欧罗拉生物科技有限公司），以促进向快速增长的亚洲市场的扩张。为了进一步扩大Aurora的市场范围，我们在全球80多个国家建立了积极的经销商网络，为客户提供销售和服务支持。
产品包括：自动化液体处理工作站、原子吸收光谱仪、原子荧光光谱仪、离子通道筛选技术和微波消解系统，它们可以在众多的应用领域中提供高销量的样品处理。我们的总部设在加拿大，并在全球有多个销售、技术支持和售后服务点。
自1990年以来，Aurora一直通过开发创新的实验室解决方案为全球科学研究界服务。Aurora集团总部位于加拿大温哥华，开始生产基于电容耦合等离子体发射专利技术的分析仪器。2000年，Aurora成为第一个开发非放射性、无标签技术，用于离子通道和转运体靶的研究和高通量筛选的公司。这项技术已迅速融入许多药物研发项目和学术实验室。利用在高通量技术方面的专业知识，Aurora将其产品扩展到包括VERSA系列的自动化液体处理平台，旨在生命科学、分子诊断和精准医疗领域。我们致力于提高人类和环境健康的质量，提供产品和服务，以促进更高的通量，同时提高质量、准确性和精确度。
自2003年起，Aurora是每年精密医疗和离子通道年会的主办方。会议旨在将业界和领先的学术研究人员聚集在一起，分享知识、交流想法，并建立富有成效的合作伙伴关系。该会议每年在加拿大和中国之间轮流召开，吸引世界各地的科学家就药物研发和个性化医学展开发人深省的讨论。它使Aurora和社会能够掌握尖端技术和创新研究的脉搏。
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a patented capacitively coupled plasma emission technology. In 2000, Aurora became the first to develop a non-radioactive, label-free technology for the study and high throughput screening of ion channel and transporter targets. This technology has been rapidly incorporated into many pharmaceutical drug discovery pipelines and academic labs. Capitalizing on this expertise in high throughput technologies, Aurora expanded its products to include the VERSA series of automated liquid handling platforms aimed at the life science, molecular diagnostics, and precision medicine fields. We are committed to improving the quality of human and environmental health by providing products and services that facilitate higher throughput while enhancing quality, accuracy, and precision.
Since 2003, Aurora been the host of the annual Precision Medicine and Ion Channel Retreat. This conference, designed to bring together industry and leading academic researchers to share knowledge, exchange ideas, and establish fruitful partnerships. This conference alternates every year between Canada and China, attracting leading scientists from around the world to engage in thought-provoking discussions on drug discovery and personalized medicine. It allows Aurora and the community to keep a pulse on cutting edge technology and innovative research.
In 2007, Aurora Biomed opened its Asia sales and services center to facilitate expansion into the rapidly growing Asia market. To further expand Aurora’s market reach, an active network of distributors based in over 80 countries worldwide, providing sales and service support to customers, was developed.
北京美科美生物技术开发有限公司
代理商实名认证
钻石会员
入驻年限：11年
